Monograph Title | Section | Source Publication | Page Number | Errata Post Date | Errata Official Date Sort ascending | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
ATORVASTATIN CALCIUM TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In Test 1, Test 3, Test 4, Test 5, and Test 6/Analysis: Change Mr1 = molecular weight of atorvastatin, 558.64 Mr2 = molecular weight of atorvastatin calcium, 1155.34 to: … Read More |
METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER | IDENTIFICATION/A. | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | Change USP Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) RS to: USP Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) RS (USP Methacrylic Acid Copolymer Type C RS) |
SITAGLIPTIN PHOSPHATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In Analysis: Change CS = concentration of USP Sitagliptin Phosphate in the Standard solution (mg/mL) to: CS = concentration of USP Sitagliptin Phosphate RS in the Standard solution (mg/mL) |
TIOCONAZOLE | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In USP Tioconazole Related Compound A RS: Change 389.73 to: 389.72 AND In USP Tioconazole Related Compound B RS: Change 458.62 to: 458.60 AND In USP Tioconazole Related Compound C RS: Change C16H13BrCl2… Read More |
ATORVASTATIN CALCIUM TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In USP Atorvastatin Related Compound B RS: Change 1155.34 to: 1155.36 |
ATORVASTATIN CALCIUM TABLETS | ASSAY/Procedure | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In Analysis: Change Mr1 = molecular weight of atorvastatin, 558.64 Mr2 = molecular weight of atorvastatin calcium, 1155.34 to: Mr1 = molecular weight of atorvastatin, 558.65 M… Read More |
METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | Change USP Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) RS (USP Methacrylic Acid Copolymer, Type C RS) to: USP Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) RS (USP Methacrylic Acid Copolymer Type C RS) |
DIGOXIN TABLETS | ASSAY/Procedure | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In Chromatographic system: Change Column: 4.2-mm × 25-cm; 5-μm packing L1 to: Column: 4.6-mm × 25-cm; 5-µm packing L1 |
METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | In USP Methylphenidate Related Compound A RS: Change α-Phenyl-2-piperidineacetic acid hydrochloride. to: (RS)-2-Phenyl-2-[(RS)-piperidin-2-yl]acetic acid hydrochloride. |
MESO-ZEAXANTHIN | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | In USP meso-Zeaxanthin RS: Change (3R,3′S-meso)-Zeaxanthin. to: (3R,3′S)-Zeaxanthin. |
<251> LEAD | PROCEDURES/Procedure 1: Chemical Method | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | In Analysis: Change Add to the acid solution 5.0 mL of Standard dithizone solution and 4 mL of Ammonia cyanide solution, to: Add to the acid solution 5.0 mL of Standard dithizone solution and 4 mL of Ammonium cyanide… Read More |
GLYCYL-L-TYROSINE | IMPURITIES/Related Compounds | USPNF Online | Online | 24-Feb-2023 | 1-Jun-2023 | NA | NA | In Buffer solution: Change Dissolve 6.84 g of potassium phosphate in 1000 mL of water. to: Dissolve 6.84 g of monobasic potassium phosphate in 1000 mL of water. |
LYSINE ACETATE | IMPURITIES/Related Compounds | USPNF Online | Online | 16-Dec-2022 | 1-Jun-2023 | NA | NA | In Chromatographic system/Spray reagent: Change 0.2 g of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5) to: 2 mg/mL of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5) |
MILBEMYCIN OXIME | CHEMICAL INFORMATION | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | Change 541.68 Milbemycin B, 5-O-demethyl-28-deoxy-25-methyl-6,28-epoxy-23-hydroxyimino-, [6R,23S,25S(E)]-; (2αE,4E,5′S,6R,6′S,8E,11R,13R,15S,17αR,… Read More |
MESO-ZEAXANTHIN | IDENTIFICATION/C. | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | Change (3R,3′S-meso)-zeaxanthin to: (3R,3′S)-zeaxanthin |
ATOVAQUONE | IMPURITIES | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | Change Related Compounds System suitability solution and Sample solution: Prepare as directed in the Assay. Analysis Samples: System suitability solution and Sample solution Using the… Read More |
ATORVASTATIN CALCIUM | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | Change USP Atorvastatin Related Compound H RS (lactone impurity) to: USP Atorvastatin Related Compound H RS Also known as Lactone impurity; AND Change USP Atorvastatin Related Compound I RS (acetonide impurity) to: USP Atorvastatin Related… Read More |
<251> LEAD | REQUIREMENTS FOR PROCEDURE VALIDATION | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | Change • Precision Repeatability to: • Precision |
OSELTAMIVIR PHOSPHATE | IMPURITIES/Organic Impurities/Procedure 3: Limit Of Tributyl Phosphine Oxide | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | In System suitability/Suitability requirements/Relative standard deviation: Change NMT 10.0% for the tributyl phosphine oxide and osteltamivir phosphate peaks to: NMT 10.0% for the tributyl phosphine oxide and oseltamivir phosphate… Read More |
METHYLPHENIDATE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | In USP Methylphenidate Related Compound A RS: Change α-Phenyl-2-piperidineacetic acid hydrochloride. to: (RS)-2-Phenyl-2-[(RS)-piperidin-2-yl]acetic acid hydrochloride. |
MESO-ZEAXANTHIN | COMPOSITION/Stereoisomeric Composition | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | In System suitability: Change [Note—The approximate relative retention times for (3S,3′S)-zeaxanthin, (3R,3′S-meso)-zeaxanthin, (3R,3′R)-zeaxanthin, and (3R,3′R,6′R)-lutein are 0.94… Read More |
LYSINE HYDROCHLORIDE | IMPURITIES/Related Compounds | USPNF Online | Online | 16-Dec-2022 | 1-Jun-2023 | NA | NA | In Chromatographic system/Spray reagent: Change 0.2 g of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5) to: 2 mg/mL of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5) |
LINEZOLID TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | In Sensitivity solution: Change 0.5 ug/mL of USP Linezolid RS from Standard solution in Diluent to: 0.5 μg/mL of USP Linezolid RS from Standard solution in Diluent |
MESO-ZEAXANTHIN | CHEMICAL INFORMATION | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | Change (3R,3′S-meso)-Zeaxanthin to: (3R,3′S)-Zeaxanthin |
RISEDRONATE SODIUM DELAYED-RELEASE TABLETS | ASSAY | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | Delete [Note—Use a non-metallic liquid chromatography system for analysis.] |
PINDOLOL | ASSAY/Procedure | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Standard stock solution: Change 1 mg/mL of USP Pindolol RS in Mobile phase prepared as follows. To a suitable amount of USP Pindolol RS add Mobile phase to fill about 90% of the total volume, and sonicate for about 5 min to… Read More |
TRIETHYL CITRATE | ASSAY/Procedure | USPNF Online | Online | 24-Feb-2023 | 1-May-2023 | NA | NA | In System suitability/Suitability requirements/Tailing factor: Change NMT 1.5 for the triethyl citrate to trimethyl citrate peaks to: NMT 1.5 for the triethyl citrate and trimethyl citrate peaks |
ESCITALOPRAM TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Test 1/Medium: Change 0.1 N hydrochloric acid VS; 900 mL to: 0.1 N hydrochloric acid; 900 mL AND In Test 2/Medium: Change 0.1 N hydrochloric acid VS; 900 mL to: 0.1 N hydrochloric acid; 900 mL |
POWDERED ROSEMARY | COMPOSITION/Content of Phenolic Diterpenes | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Sample solution: Change Before injection, pass through a membrane filter of 0.45-µL or finer pore size, to: Before injection, pass through a membrane filter of 0.45-µm or finer pore size, |
ISOFLURANE | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Analysis: Change Result = (rU/rS) × CS × (1/F) to: Result = (rU/rS) × CF × (1/F) AND Change CS… Read More |
FLUTICASONE PROPIONATE NASAL SPRAY | OTHER COMPONENTS/Content of Phenylethyl Alcohol | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Sample solution: Change Transfer 1.0 g of the Nasal Spray to a 50-mL volumetric flask. Add about 40 mL of Diluent, and sonicate for 10 min until the supernatant is clear. Use the clear supernatant for analysis. to: Transfer 1.0 g of the… Read More |
PSEUDOEPHEDRINE HYDROCHLORIDE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | Change Uniformity of Dosage Units 〈905〉 Procedure for content uniformity to: Uniformity of Dosage Units 〈905〉: Meets the requirements Procedure for content uniformity, chewable tablets only AND In … Read More |
ACYCLOVIR | ASSAY/Procedure | USPNF Online | Online | 29-Apr-2022 | 1-May-2023 | NA | NA | In the Sample solution: Change 0.1 N sodium hydroxide to: 0.01 N sodium hydroxide |
ACARBOSE TABLETS | IDENTIFICATION/B. | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | Change The spectrum obtained from the Sample solution shows IR maxima in the regions of 3500–3200, 2950–2890, 1653–1633, and 1070–1000 cm–1. to: The spectrum obtained from the sample preparation shows IR maxima in the regions of 3500–3200… Read More |
VIGABATRIN TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Analysis: Change CS = concentration of USP Vigabatrin Related Compound A in the Standard solution to: CS = concentration of USP Vigabatrin Related Compound A RS in the Standard solution |
DEXTRATES | ASSAY/Dextrose Equivalent | USPNF Online | Online | 31-Mar-2023 | 1-May-2023 | NA | NA | In Analysis: Change rA = peak response of each saccharide degree of polymerization (DP1–DP3) in the Sample solution (If any peaks of DP4 and above are observed in the sample, take the summation… Read More |
ROSEMARY LEAF DRY AQUEOUS EXTRACT | COMPOSITION/Content of Rosmarinic Acid | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Standard solution B: Change Before injection, pass through a membrane filter of 0.45-µL or finer pore size, to: Before injection, pass through a membrane filter of 0.45-µm or finer pore size, AND In Sample solution: Change … Read More |
BUPIVACAINE HYDROCHLORIDE INJECTION | ASSAY/Procedure | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Chromatographic system/Column: Change 4-mm × 30-cm; packing L1 to: 3.9-mm × 30-cm; packing L1 AND In System suitability: Change [Note—The relative retention times for bupivacaine hydrochloride and dibutyl phthalate are… Read More |
ESCITALOPRAM TABLETS | ASSAY/Procedure | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Buffer: Change Adjust with 1 N sodium hydroxide VS to a pH of 5.2. to: Adjust with 1 N sodium hydroxide to a pH of 5.2. |
<1042> CELL BANKING PRACTICES FOR RECOMBINANT BIOLOGICS | 5. CELL BANK CHARACTERIZATION | USPNF Online | Online | 31-Mar-2023 | 1-May-2023 | NA | NA | In Table 4: Change In vitro assayd,e + + +f to: In vitro assayd,e + −f + |
ROSEMARY | COMPOSITION/Content of Phenolic Diterpenes | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Sample solution: Change Before injection, pass through a membrane filter of 0.45-µL or finer pore size, to: Before injection, pass through a membrane filter of 0.45-µm or finer pore size, |
BISOPROLOL FUMARATE | CHEMICAL INFORMATION | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | Change (±)-1-[[α-(2-Isoproproxyethoxy)-p-tolyl]oxy]-3-(isopropyl amino)-2-propanol fumarate (2:1) (salt) to: (±)-1-[[α-(2-Isoproproxyethoxy)-p-tolyl]oxy]-3-(isopropylamino)-2-propanol fumarate (2:1) (salt) |
DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES | IDENTIFICATION | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | Change A. The UV-Vis spectrum of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay. to: A. The UV spectrum of the major peak of the Sample solution… Read More |
FLUVOXAMINE MALEATE TABLETS | ASSAY/Procedure | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Solution A: Change 8 g/L of 1-pentanesulfonic acid sodium salt and 1 g/L of monobasic potassium phosphate in water. to: 8 g/L of 1-pentanesulfonic acid sodium salt and 1.1 g/L of monobasic potassium phosphate in water. |
ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE TABLETS | IMPURITIES/Limit of 2-Methylbenzhydrol | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Standard solution: Change 7.5 µg/mL of USP 2-Methylbenzhydrol RS in methanol to: 7.5 µg/mL of USP Methylbenzhydrol RS in methanol AND In Analysis: Change CS = concentration of USP 2-Methylbenzhydrol RS in the… Read More |
ERYTHROMYCIN ETHYLSUCCINATE FOR ORAL SUSPENSION | Identification | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | Change Proceed as directed in the Identification test under Erythromycin Ethylsuccinate Oral Suspension, beginning with “Prepare a Standard solution.” to: Prepare a Standard solution of USP Erythromycin Ethylsuccinate RS in methanol… Read More |
<209> LOW MOLECULAR WEIGHT HEPARIN MOLECULAR WEIGHT DETERMINATIONS | PROCEDURE | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In footnote 1 in Molecular Weight Measurements of Low Molecular Weight Heparins by Gel Permeation Chromatography/Chromatographic system/Columns/Analytical: Change guard column TSK SWXL 6-mm × 4-mm; to: guard column TSK… Read More |
THYROID TABLETS | ASSAY/Procedure | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Chromatographic system: Change Column: 4.6-cm × 25-cm; packing L1 to: Column: 4.6-mm × 25-cm; packing L1 |
PRAZOSIN HYDROCHLORIDE CAPSULES | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Test 2/Analysis: Change CS = concentration of USP Prazosin Hydrochloride RS in the Standard solution (µg/mL) to: CS = concentration of USP Prazosin Hydrochloride RS in the Standard… Read More |
ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | Change USP 2-Methylbenzhydrol RS to: USP Methylbenzhydrol RS |